Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1698-1705

  Sabbah, Hani N ^a,b   Sharov, Victor G ^a   Gupta, Ramesh C ^a   Todor, Anastassia ^a   Singh, Vinita ^a   Goldstein, Sidney ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CASPASE; DNA; METOPROLOL; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA STRAND BREAKAGE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALSEQUESTRIN; CASPASE 3; CASPASES; DNA; DOGS; GENES, BCL-2; HEART FAILURE, CONGESTIVE; METOPROLOL; MYOCARDIUM; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0034332916     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00913-X     Document Type: Article

References (32)

1. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial
2. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
3. Effects of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized double blind, placebo-controlled study
4. Effects of long-term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction
5. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
6. Apoptosis in the failing human heart
7. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
8. 2+
9. Angiotensin-II induces apoptosis of adult ventricular myocytes in vivo
10. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of beta-adrenergic pathway
11. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
12. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations
13. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure
14. Abnormalities of cardiocytes in regions bordering fibrous scars in dogs with heart failure
15. 2+-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure
16. 2+-ATPase activity and expression in ventricular myocardium of dogs with heart failure
17. A sharper Bonferroni procedure for multiple tests of significance
18. Apoptotic cell death in heart failure
19. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
20. Elevated DNase I levels in human idiopathic dilated cardiomyopathy: An indicator of apoptosis
21. Adrenergic effects on the biology of the adult mammalian cardiocyte
22. 2- adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein
23. Programmed myocyte cell death affects the viable myocardium after infarction in rats
24. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-X(L)
25. Progression of heart failure: A role for interstitial fibrosis
26. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
27. Mechanisms of apoptosis regulation: Relevance to heart disease
28. Staurosporine-induced apoptosis in cardiomyocytes: A potential role for caspase-3
29. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat
30. Bcl-2 expression prevents activation of ICE protease cascade
31. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states
32. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias